-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on BioNTech, Lowers Price Target to $125

Benzinga·08/05/2026 18:59:23
Listen to the news
Citigroup analyst Geoff Meacham maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price target from $130 to $125.